HOXB13 and Familial prostate cancer: Prostein and PSA correctly detected 82% of cases, HOXB13 and PSA labeled 94.2% of cases correctly, AR and PSA detected 100% of cases, and ERG and PSA recognized 88% of prostate cancer metastases.